Drug Interactions Between Peficitinib, an Orally Administered, Once-Daily Janus Kinase Inhibitor, and Rosuvastatin in Healthy Subjects
Crossref DOI link: https://doi.org/10.1007/s40262-016-0474-4
Published Online: 2016-11-22
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Tong
Parker, Barbara
Wojtkowski, Tomasz
Nishimura, Tetsuya
Garg, Jay P.
Han, David
Fisniku, Ogert
Keirns, James
Funding for this research was provided by:
Astellas Pharma Global Development Inc.
License valid from 2016-11-22